Keywords: strong, efficacy, data, pfizer, lyrica, findings, new
Strong efficacy data for Pfizer's Lyrica
Article | 04 December 2006
Findings from a new study published in the Novermber 28 issue of the journal Neurology demonstrate that Pfizer's neuropathic painkiller Lyrica ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
